Skip to search formSkip to main contentSkip to account menu

SPC 703

Known as: SPC-703 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
The effects of oral hypoglycaemic drugs, SPC-703 (n-/p-toluenesulphonyl/-5-methyl-2-pirazoline-1-carbonami de) and tolbutamide on… 
1984
1984
The effect of oral hypoglycaemic drugs, SPC-703 [n-(p-toluenesulphonyl)-5-methyl-2-pirazoline-1-carbonami de] and tolbutamide on… 
1980
1980
Pharmacokinetic of a new hypoglycemic agent, SPC-703 was studied in rats after iv, ip and po administration of two doses of the… 
1980
1980
Over 60% of a dose of N-(p-toluenesulfonyl)-5-methyl-2-pyrazoline-1-carbonamide (SPC-703) given to humans or rats was excreted… 
1979
1979
New oral hypoglycemic drug, SPC-703, given in doses of 100 and 200 mg/kg iv rised the arterial pressure in the rat. In the… 
1976
1976
Bovine serum albumin has two different binding sites for sulfonylurea. The sites at high affinity can bind up to 2 moles of a new…